Inspire Medical Systems (NYSE:INSP – Get Free Report)‘s stock had its “overweight” rating restated by equities research analysts at KeyCorp in a research note issued to investors on Friday,Benzinga ...
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $231.12, a high ...
Lawrence Zarian is back with MorningSave.com to give you four incredible products that will help inspire you in 2025! If you ...
KeyBanc Capital Markets adjusted its price target on Inspire Medical Systems (NYSE:INSP) shares, lowering it to $234 from $236, while maintaining an Overweight rating on the stock. The revision ...
In a report released today, Brett Fishbin from KeyBanc maintained a Buy rating on Inspire Medical Systems (INSP – Research Report), with a ...
KeyBanc lowered the firm’s price target on Inspire Medical (INSP) to $234 from $236 and keeps an Overweight rating on the shares after the ...